Minerva
A rash refractory to treatment
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1703 (Published 30 April 2020) Cite this as: BMJ 2020;369:m1703
- Mark Eisner, LAS dermatology,
- Elizabeth West, consultant dermatologist
- Department of Dermatology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
- Correspondence to M Eisner mark.eisner{at}liverpoolft.nhs.uk
This (fig 1) is carcinoma erysipeloides (cutaneous metastatic breast cancer), of a woman in her 70s. She presented with an eight month history of …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.